{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:38:02Z","timestamp":1793050682642,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00256-019-03325-7","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T03:04:21Z","timestamp":1572231861000},"page":"483-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation"],"prefix":"10.1007","volume":"49","author":[{"given":"Ayca","family":"Dundar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris E.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie Y.","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5391-9537","authenticated-orcid":false,"given":"Stephen M.","family":"Broski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"6","key":"3325_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.semarthrit.2010.07.005","volume":"40","author":"S Ottaviani","year":"2011","unstructured":"Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum. 2011;40(6):539\u201346.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"3325_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1302\/0301-620X.95B3.30192","volume":"95","author":"J Stevenson","year":"2013","unstructured":"Stevenson J, Jaiswal A, Gregory J, Mangham D, Cribb G, Cool P. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle. Bone Joint J. 2013;95(3):384\u201390.","journal-title":"Bone Joint J"},{"key":"3325_CR3","first-page":"731","volume":"31","author":"HL Jaffe","year":"1941","unstructured":"Jaffe HL. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941;31:731\u201365.","journal-title":"Arch Pathol"},{"issue":"2","key":"3325_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/his.13744","volume":"74","author":"MJ Mastboom","year":"2019","unstructured":"Mastboom MJ, Hoek DM, Bov\u00e9e JV, van de Sande MA, Szuhai K. Does CSF 1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Histopathology. 2019;74(2):332\u201340.","journal-title":"Histopathology"},{"issue":"3","key":"3325_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1073\/pnas.0507321103","volume":"103","author":"RB West","year":"2006","unstructured":"West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci. 2006;103(3):690\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"3325_CR6","first-page":"281","volume-title":"WHO classification of tumours of soft tissue and bone. Tumours of soft tissue: introduction","author":"Organization WH, Cancer IAfRo","year":"2013","unstructured":"Organization WH, Cancer IAfRo. WHO classification of tumours of soft tissue and bone. Tumours of soft tissue: introduction. Geneva: WHO; 2013. p. 281\u201395."},{"issue":"5","key":"3325_CR7","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1148\/rg.285085134","volume":"28","author":"MD Murphey","year":"2008","unstructured":"Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493\u2013518.","journal-title":"Radiographics."},{"issue":"10","key":"3325_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2217\/fon.13.124","volume":"9","author":"FG Verspoor","year":"2013","unstructured":"Verspoor FG, van der Geest IC, Vegt E, Veth RP, van der Graaf WT, Schreuder HW. Pigmented villonodular synovitis: current concepts about diagnosis and management. Future Oncol. 2013;9(10):1515\u201331.","journal-title":"Future Oncol"},{"issue":"1","key":"3325_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10067-003-0827-x","volume":"23","author":"XG Cheng","year":"2004","unstructured":"Cheng XG, You YH, Liu W, Zhao T, Qu H. MRI features of pigmented villonodular synovitis (PVNS). Clin Rheumatol. 2004;23(1):31\u20134.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3325_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-2003-43231","volume":"7","author":"S Masih","year":"2003","unstructured":"Masih S, Antebi A. Imaging of pigmented villonodular synovitis. Semin Musculoskelet Radiol. 2003;7(3):205\u201316.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"5","key":"3325_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/15513819209024226","volume":"12","author":"GH Kang","year":"1992","unstructured":"Kang GH, Chi JG, Choi IH. Pigmented villonodular synovitis in the sacral joint with extensive bone destruction in a child. Pediatr Pathol. 1992;12(5):725\u201330.","journal-title":"Pediatr Pathol"},{"issue":"1","key":"3325_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1148\/89.1.54","volume":"89","author":"A Melamed","year":"1967","unstructured":"Melamed A, Bauer CA, Johnson JH. Iliopsoas bursal extension of arthritic disease of the hip. Radiology. 1967;89(1):54\u20138.","journal-title":"Radiology"},{"issue":"19","key":"3325_CR13","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","volume":"124","author":"J-F Emile","year":"2014","unstructured":"Emile J-F, Diamond EL, H\u00e9lias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, et al. Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood. 2014;124(19):3016\u20139.","journal-title":"Blood"},{"issue":"2","key":"3325_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0033-1343095","volume":"17","author":"HW Garner","year":"2013","unstructured":"Garner HW, Bestic JM. Benign synovial tumors and proliferative processes. Semin Musculoskelet Radiol. 2013;17(2):177\u20138.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"6","key":"3325_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.rcl.2007.08.008","volume":"45","author":"MA Frick","year":"2007","unstructured":"Frick MA, Wenger DE, Adkins M. MR imaging of synovial disorders of the knee: an update. Radiol Clin N Am. 2007;45(6):1017\u201331 vii.","journal-title":"Radiol Clin N Am"},{"issue":"1","key":"3325_CR16","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/RLU.0000000000000893","volume":"41","author":"SM Broski","year":"2016","unstructured":"Broski SM, Murdoch NM, Skinner JA, Wenger DE. Pigmented villonodular synovitis: potential pitfall on oncologic 18F-FDG PET\/CT. Clin Nucl Med. 2016;41(1):e24\u201331.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"3325_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0009-9260(97)80250-4","volume":"52","author":"S Eustace","year":"1997","unstructured":"Eustace S, Goldberg R, Williamson D, Melhem E, Oladipo O, Yucel E, et al. MR imaging of soft tissues adjacent to orthopaedic hardware: techniques to minimize susceptibility artefact. Clin Radiol. 1997;52(8):589\u201394.","journal-title":"Clin Radiol"},{"issue":"5","key":"3325_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2967\/jnumed.117.200741","volume":"59","author":"JR Young","year":"2018","unstructured":"Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. (18)F-FDG PET\/CT in Erdheim-Chester disease: imaging findings and potential BRAF mutation biomarker. J Nucl Med. 2018;59(5):774\u20139.","journal-title":"J Nucl Med"},{"issue":"5","key":"3325_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","volume":"33","author":"J Haroche","year":"2014","unstructured":"Haroche J, Cohen-Aubart F, Emile J-F, Maksud P, Drier A, Tol\u00e9dano D, et al. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol. 2014;33(5):411\u20138.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3325_CR20","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1002\/art.24848","volume":"60","author":"L Arnaud","year":"2009","unstructured":"Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, et al. 18F-fluorodeoxyglucose\u2013positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease. Arthritis Rheum. 2009;60(10):3128\u201338.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3325_CR21","first-page":"14","volume":"8","author":"A Sakamoto","year":"2018","unstructured":"Sakamoto A, Matsuyama A, Hisaoka M, Matsuda S. Bone involvement mimicking an aggressive bone lesion in a diffuse-type tenosynovial giant cell tumor in the thoracic vertebral lamina: a case report. J Orthop Case Reports. 2018;8(3):14.","journal-title":"J Orthop Case Reports"},{"issue":"2","key":"3325_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/radiol.2382041525","volume":"238","author":"E Dion","year":"2006","unstructured":"Dion E, Graef C, Miquel A, Haroche J, Wechsler B, Amoura Z, et al. Bone involvement in Erdheim-Chester disease: imaging findings including periostitis and partial epiphyseal involvement. Radiology. 2006;238(2):632\u20139.","journal-title":"Radiology"},{"issue":"4","key":"3325_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13244-014-0331-7","volume":"5","author":"C Antunes","year":"2014","unstructured":"Antunes C, Graca B, Donato P. Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings. Insights Imaging. 2014;5(4):473\u201382.","journal-title":"Insights Imaging"},{"issue":"4","key":"3325_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","volume":"124","author":"EL Diamond","year":"2014","unstructured":"Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124(4):483\u201392.","journal-title":"Blood"},{"issue":"2","key":"3325_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.canlet.2007.05.003","volume":"255","author":"A Geldyyev","year":"2007","unstructured":"Geldyyev A, Koleganova N, Piecha G, Sueltmann H, Finis K, Ruschaupt M, et al. High expression level of bone degrading proteins as a possible inducer of osteolytic features in pigmented villonodular synovitis. Cancer Lett. 2007;255(2):275\u201383.","journal-title":"Cancer Lett"},{"issue":"10","key":"3325_CR26","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","volume":"117","author":"L Arnaud","year":"2011","unstructured":"Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117(10):2778\u201382.","journal-title":"Blood"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-019-03325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00256-019-03325-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-019-03325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:13:17Z","timestamp":1603757597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00256-019-03325-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3325"],"URL":"https:\/\/doi.org\/10.1007\/s00256-019-03325-7","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The need for informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}